Facility Expansion Signature Biologics has recently expanded to a newly constructed 36,000 square foot facility in Irving, Texas, signaling capacity growth and potential demand for contract development and manufacturing services in cellular therapeutics and biologics.

Small to Mid-Size Focus With a team size of 11-50 employees and revenue in the 10-25 million range, they present as a nimble, specialized partner for biotech firms seeking flexible CDMO capabilities without the scale of mega-pharmas.

GMP Cellular Expertise Positioned as a GMP manufacturing and development facility for cellular therapeutics and biologics, there is opportunity to offer process development, scale-up, analytics, and regulatory support tailored to early-stage and mid-stage programs.

Texas Presence Located in Irving, Texas with recent expansion, there is potential to engage regional biotech firms and academic collaborations in the Southwest, leveraging proximity for faster CDMO-to-clinic timelines.

Growth & Funding Signals Revenue scale combined with facility expansion indicates growth momentum; sales strategies could target companies preparing for GMP manufacturing transfer, tech transfer partnerships, or follow-on funding rounds needing scalable manufacturing options.